Join us for the official launch of DiMe’s Integrated Evidence Plans (IEP) resources, designed to help you overcome key challenges in evidence generation and commercial adoption of digital health technologies (DHTs)!
Join us for our launch, “Unlocking impact through investment: Building the business case for digital endpoints,” on Mar. 26 at 11 a.m. ET. Learn how new resources support you in measuring ROI and building your business case for digital endpoints.
Showcasing biotech success stories: digital endpoints in clinical trials
Date/Time
Panelists
Moderator
Discussion Topic
Around half of the sponsors included in DiMe’s Library of Digital Endpoints are biotech companies. Despite these organizations having access to fewer resources compared to larger pharmaceutical counterparts, they’ve championed digital innovation as a means to achieving success in their clinical programs and propelling their business forward. Join this discussion to learn how biotech leaders have successfully adopted digital endpoints in their clinical trials and learn more about the challenges they encountered, the solutions they developed, and their perspectives on the value of digital endpoints for biotechs.
